Top 26-30
09 June 2011 | News
 |
Advanced Enzyme Technologies | Advanced
Enzyme
Technologies (AETL) clocked total sales revenue of  154 crore
for FY 2010-11 as compared to 121 crore in 2009-10. The revenue is
expected to increase 30 to 35 percent on a year-on-year basis for the
next five to eight years. The company operates primarily in four
segments, including human health & nutrition, animal nutrition,
food processing, and industrial processing. The company is expected to
start its European and Chinese subsidiaries soon. More than 50 percent
of the company’s sales come from its exports to 53 countries. AETL,
which had a overhaul in 2009, developed more than 400 unique enzyme
products like luicine amino peptidase (exo-peptidase), candida
antarctica lipase b immobilized, a full range of hemicellulase and
pectinase enzymes and a full range of grain ethenol enzymes. AETL is
also the largest manufacturer of serratiopeptidase, having perfected
the art of manufacturing the enzyme over the past 15 years. |
| CEO Dr CL Rathi |
||
|
26
|
Business: Manufacturing, R&D and marketing of enzymes | |
| Start-up Year: 1989 | ||
| Address:
Sun Magnetica, “A” wing, 5th Floor, LIC Service Road, Louiswadi, Thane
(W)- 400 604 |
||
| Tel: +91-22-41703200 Fax: +91-22-25835159 Website: www.enzyme.com |
||
| Revenue: 154
crore* |
||
 |
Lambda Therapeutic Research | Lambda
Therapeutic
Research recorded an estimated sales revenue of 128 crore
for 2010-11. The company offers services such as clinical trials
implementation, laboratory and data management, information technology
support, medical affairs assistance, quality assurance and bio
analysis. The CRO has more than 640 clinical beds globally, including a
16-bed phase I unit in Ahmedabad, a 12-bed phase I unit in Toronto,
Canada, a six-bed phase I unit in Warsaw, Poland. The company also has more than 40 LC-MS/MS systems, a CAP/NGSP accredited clinical laboratory, molecular and microbiological laboratory and a low temperature (2-8 °C, -20 °C and -80 °C) controlled storage facility, to store over 4.0 million samples. Lambda Therapeutic Research has additional facilities in Mumbai, India and Erwitte, Germany and has acquired a pharmacovigilance CRO in UK, named Pharm V Solutions. |
| MD Ms Bindi Chudgar |
||
|
27
|
Business: Clinical trials implementation, laboratory and data management | |
| Start-up Year: 1999 | ||
| Address: Near Gujarat High Court, S. G. Highway, Gota, Ahmedabad-380061 |
||
| Tel: +91-79-40202020 Fax: +91-79-40202021 Website: www.lambda-cro.com |
||
| Revenue: 128 crore* |
||
 |
Concord Biotech | Concord
Biotech,
a R&D-based company that focuses on fermentation and
semi-synthetic based products, achieved a total income of 126.17 crore
in FY 2010-11 as compared to 111.07 crore in the previous year. It is
the largest producer of penicillin-G amidase enzyme, with a market
share of 90 percent. It exports this enzyme to a number of companies in
China, Europe and the US. Concord also produces and exports lovastatin
and tacrolimus and is also starting the production of simvastatin and
pravastatin in its new US-FDA approved facility. It now boasts of
having one of the largest numbers of bioreactors in India and has setup
a lyophilization facility for sterile bulk biopharmaceutical. It also
has a manufacturing facility, spread across 28 acres of land, located
at Ahmedabad, Gujarat. In FY2010-11, Concord initiated its CRAM
business by setting up of its new R&D facility. The company
received award for its outstanding contribution to the healthcare
sector at Bangalore India Bio 2011. |
| MD
and CEO Mr Sudhir Vaid |
||
|
28
|
Business: Manufacturing of bulk drugs | |
| Start-up
Year: 2002 |
||
| Address:
302, Sakar-III, Opp: Gujarat High Court, Off ITO Circle, Ashram Road,
Ahmedabad-380014 |
||
| Tel: +91-79-27544998, 27543557 Fax: +91-79-27540802 Website: www.concordbiotech.com |
||
| Revenue: 126.17 crore |
||
 |
Ecron Acunova | Ecron
Acunova
is a Bangalore-based CRO with offices across India and
operations in 14 European countries. The company recorded revenue worth
125 crore in the FY 2010-11 as compared
to 97 crore in FY 2009-10. In
January 2011, Ecron Acunova expanded its clinical research center for
drug development by 80 beds. The company also announced a joint venture
with Jamjuree Innovations(JJI), Thailand and will conduct clinical
research in key South East Asian countries under the name, Ecron
Acunova Company Limited (EACL). In April 2011, Ecron Acunova acquired a majority stake in aCROnordic, a Danish CRO specializing in clinical research in Sweden, Finland and Norway. Since its inception five years ago Ecron has conducted over 250 phase I one studies and over 70 late phase studies, which has helped the company reach the third position amongst nearly 100 CROs in India. |
| Founder
& Chairman Mr DA Prasanna |
||
|
29
|
Business: Clinical research services | |
| Start-up Year: 1986 | ||
| Address: Manipal Acunova Limited,
Mobius Towers, SJR i-Park, EPIP, Whitefield, Bangalore-560066 |
||
| Tel: +91-80-66915700 Fax: +91-80-66915719 Website: www.ecronacunova.com |
||
| Revenue: 125 crore* |
||
 |
Themis Medicare | Themis
Medicare
(TML) achieved a total turnover of 124 crore as against 90
crore for the year ending March 31, 2010. TML has a plant located in Hyderabad where lovastatin, simvastatin and other fermentation-based actives are produced. TML boasts of four state-of-the-art manufacturing facilities at three locations, in Vapi (Gujarat), Hyderabad (Andhra Pradesh) and Haridwar (Uttaranchal). The company has a joint venture partnership with Gedeon Richter (Budapest, Hungary), named Richter-Themis Medicare (India) Private Limited and also has signed a long-term business agreement with Schering-Plough Animal Health Corporation, US (SPAH). Although its first breakthrough product was vitamin B12, TML moved on to manufacture several synthetic API and numerous therapeutics. |
| MD
and CEO Dr Dinesh Patel |
||
|
30
|
Business: Formulations and API of synthetic origin | |
| Start-up Year: 1969 | ||
| Address:
11/12, Udyog Nagar, S.V.Road, Goregaon (West), Mumbai-400 104 |
||
| Tel: +91-22-67607080, 28757836 Fax: +91-22-28746621 Website: www.themismedicare.com |
||
| Revenue: 124
crore* |
||
